 |
|
MRC Scientists Find Better Way to Predict the Outcome of Breast Cancer Following Surgery
December 03, 2003MRC Scientists have found a better way to predict the outcome of breast cancer following surgery which might lead to the improved management of the disease.
The discovery, published in the Journal of Clinical Oncology, complements the methods doctors currently use to predict the outcome of breast cancer following surgery in order to choose the best course of treatment for individual patients.
The research team, led by Dr Nicholas Coleman of the MRC Cancer Cell Unit, examined breast cancer tissue removed in surgery and found that a protein called Mcm-2 gives a more precise indication of how quickly tumour cells in breast cancer grow.
This allows doctors to establish the status of the disease more accurately, which in turn helps them make better predictions of overall survival and to determine the chances of a tumour recurring after treatment or of the cancer spreading to other organs.
Dr Coleman said:
"This is good news for women with breast cancer as an accurate assessment of the outcome following surgery is key to choosing how much further therapy is needed for an individual patient. It is important that patients receive neither too little nor too much additional treatment for their tumours.
"The discovery has the potential to make a difference to the lives of thousands of women as breast cancer is the most common type of cancer to affect women in the UK."
Cancer Research UK (CRUK) also funded the research. Professor Robert Souhami, CRUK's Director of Clinical and External Affairs, said:
"This research shows that levels of MCM2 may provide additional information about outcome in breast cancer. The findings will hopefully prove helpful to doctors when choosing the most effective approach to treatment."
Further research is now required to validate these results before they can be used in routine clinical practice.
Breast cancer accounts for almost one in three of all cancers in women. Each year there are nearly 41,000 new cases in the UK.
Medical Research Council
This allows doctors to establish the status of the disease more accurately, which in turn helps them make better predictions of overall survival and to determine the chances of a tumour recurring after treatment or of the cancer spreading to other organs.
Dr Coleman said:
"This is good news for women with breast cancer as an accurate assessment of the outcome following surgery is key to choosing how much further therapy is needed for an individual patient. It is important that patients receive neither too little nor too much additional treatment for their tumours.
"The discovery has the potential to make a difference to the lives of thousands of women as breast cancer is the most common type of cancer to affect women in the UK."
Cancer Research UK (CRUK) also funded the research. Professor Robert Souhami, CRUK's Director of Clinical and External Affairs, said:
"This research shows that levels of MCM2 may provide additional information about outcome in breast cancer. The findings will hopefully prove helpful to doctors when choosing the most effective approach to treatment."
Further research is now required to validate these results before they can be used in routine clinical practice.
Breast cancer accounts for almost one in three of all cancers in women. Each year there are nearly 41,000 new cases in the UK.
Medical Research Council
Breast Cancer Current Events and Breast Cancer News RSSMenopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.
Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.
UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
Fertility procedures need not delay breast cancer treatment for younger women
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
Coffee break: Compound brewing new research in colon, breast cancer
A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.
Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.
Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe
The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated.
Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.
More Breast Cancer Current Events and Breast Cancer News Articles
 |
New Balance Women's Lace Up X Out Breast Cancer Tech Tee (Athletic Grey, Small) by New Balance The New Balance X Out Breast Caner Tee has a soft hand and clearly states how everyone feels! |
 |
1149 WOMENS VINTAGE BLACK ADJUSTABLE FATIGUE CAP w/PINK STRIPES & ''BREAST CANCER'' RIBBON by Rothco A portion of these proceeds go to the Babylon Breast Cancer Coalition- For Life, For Hope, For Change, For the Future Visit www.babylonbreastcancer.org for more information. |
 |
Just Get Me Through This!: The Practical Guide to Breast Cancer by Deborah A. Cohen (Author), M.D., Robert M. Gelfand (Author) |
 |
Fox Run Breast Cancer Awareness Baking Set by Fox Run Support Breast Cancer awareness in a sweet way with this five piece set. Bake cookies using the ribbon cookie cutters or cupcakes using the white paper bake cups with the pattern of pink ribbons. Decorate both with the included 4 in 1 sprinke assortement jar. The set also includes a pink silicone spoon spatula to help mix up your favorite batch of cookie dough. |
 |
Avon Breast Cancer Crusade Flip-Flop Necklace by Avon Silvertone pendant with rhinestone and pink enamel-look accents. We Walk As One inscribed on back. 17" silvertone chain with 3" extender.100% of the net proceeds ($3.36)will be donated to the Avon Breast Cancer Crusade. 100% of the profits ($3.37) will be donated to the Avon Breast Cancer Crusade.... Please note that in your shipping confirmation you will be asked to let us know if you are currently receiving service from an Avon Representative. If you are, please follow the link provided in the confirmation so that s/he can receive proper credit for your Avon order placed through Amazon.com. |
 |
Wrangler Women's Tough Enough To Wear Pink Breast Cancer Awareness Jacket,Pink,X-Large by Wrangler Are you tough enough to wear pink? That is the question the western industry asked 12/9/05 at the Wrangler National Finals Rodeo (Wrangler NFR), the "Super Bowl of pro rodeo," as it launched Tough Enough to Wear Pink (TETWP). TETWP is a multi-year, western-industry-wide fundraiser to raise awareness and funds for breast cancer research. TETWP partners are ponying up to support this cause by manufacturing pink merchandise with proceeds benefiting breast cancer research. By wearing this Tough Enough to Wear Pink shirt you are helping in the fight against breast cancer. This TETWP shirt is a pink cotton plaid. Import. Tough Enough to Wear Pink. long sleeve zip front jacket with zippered front slash pockets and the breast cancer embroidery on left chest. 100% Polyester Fleece/100% Nylon... |
 |
Raymond Geddes National Breast Cancer Foundation Pen (67709) by Raymond Geddes Breast Cancer Awareness Pen, Join Geddes in supporting the National Breast Cancer Foundation and the fight against Breast Cancer. Assortment contains pink pens with pink ribbons. Retractable, black in pen ink. 5 1/2" long. |
 |
Chicken Soup for the Breast Cancer Survivor's Soul: Stories to Inspire, Support and Heal (Chicken Soup for the Soul) by Jack Canfield (Author), Mark Victor Hansen (Author), Mary Olsen Kelly (Author) Your support group in a book, filled with boundless strength and profound hope - until the fight is won. Along with the shock, fear and loss many women face upon a breast cancer diagnosis comes unexpected strength, wisdom, and strong networks of sharing, support and healing. In Chicken Soup for the Breast Cancer Survivor's Soul, survivors and their family members talk openly about how difficult their fight with breast cancer has been and how they made it through the dark times with a belief in a higher power and the support of those closest to them. Find strength in the encouraging stories of how family members confront their fears and show genuine affection for one another through gestures such as a granddaughter cutting the hair off of all her dolls so that they will... |
 |
Find the Cure Pink Breast Cancer Awareness Wristband by sci Find The Cure Pink Breast Cancer Awareness wristband |
 |
Sunbeam Camelot Microplush Heated Throw, Breast Cancer Awareness Pink by Sunbeam Soft comfortable fabric that you can cuddle up with anywhere in your house. Use it on the couch while curling up to read a good book or in a chair while watching your favorite show. This throw is 50"x60", with a primstyle control which features 3 warming settings and 3 hour auto-off. So turn on your warming blanket, turn off your thermostat and save on your heating bill. Warm up to a good cause! Sunbeam is joining the fight against breast cancer. Through the purchase of this pink throw, sunbeam will donate $1.00 to city of hope for breast cancer research, treatment and education* up to $25,000. Program ends april 30, 2009. "to save lives and end breast cancer forever by empowering people, ensuring quality care for all, and energizing science to find the cures." *to learn more about... |
| © 2009 BrightSurf.com |